Keywords: guanfacine, ADHD, pediatric, toxicity (PubMed Search)
Guanfacine is a presynaptic alpha-2 adrenergic receptor agonist (similar to clonidine) that is FDA approved to treat ADHD in pediatric patients 6 years of age and older. A recently published study characterized the pediatric exposure to guanfacine between 2000 and 2016.
Most frequently reported clinical effect (n=10927)
Severe clinical effects (n=10927)
Duration of clinical effect